Publications:

TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm.

Blood Advances

Beird, Hannah C HC; Yin, C Cameron CC; Khoury, Joseph D JD; Pierce, Sherry R SR; Abbas, Hussein A HA; Zhao, Li L; Skwarska, Anna A; Qazilbash, Muzaffar H MH; Konopleva, Marina Y MY; Futreal, Andrew A; Pemmaraju, Naveen N

Publication Date: 2023-01-23

Variant appearance in text: TET2: Y1345*

PubMed Link: 36689729

Variant Present in the following documents:

• BLOODA_ADV-2022-007879-mmc1.pdf

View BVdb publication page

Myeloid Clonal Infiltrate Identified With Next-Generation Sequencing in Skin Lesions Associated With Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: A Case Series.

Frontiers In Immunology

Martin de Frémont, Grégoire G; Hirsch, Pierre P; Gimenez de Mestral, Santiago S; Moguelet, Philippe P; Ditchi, Yoan Y; Emile, Jean-François JF; Senet, Patricia P; Georgin-Lavialle, Sophie S; Hanslik, Thomas T; Maurier, François F; Adedjouma, Amir A; Abisror, Noémie N; Mahevas, Thibault T; Malard, Florent F; Adès, Lionel L; Fenaux, Pierre P; Fain, Olivier O; Chasset, François F; Mekinian, Arsène A

Publication Date: 2021

Variant appearance in text: TET2: 4035T>A; Tyr1345*

PubMed Link: 34671345

Variant Present in the following documents:

• Main text
• fimmu-12-715053.pdf

View BVdb publication page